Breast Multiparametric MRI for Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: The BMMR2 Challenge-Reference-Cited by-同舟云学术

Breast Multiparametric MRI for Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: The BMMR2 Challenge

Published:2024-01-01 Issue:1 Volume:6 Page:
ISSN:2638-616X
Container-title:Radiology: Imaging Cancer
language:en
Short-container-title:Radiology: Imaging Cancer

Author:

Li Wen^ORCID,Partridge Savannah C.^ORCID,Newitt David C.^ORCID,Steingrimsson Jon,Marques Helga S.,Bolan Patrick J.^ORCID,Hirano Michael,Bearce Benjamin Aaron,Kalpathy-Cramer Jayashree^ORCID,Boss Michael A.^ORCID,Teng Xinzhi,Zhang Jiang^ORCID,Cai Jing,Kontos Despina^ORCID,Cohen Eric A.^ORCID,Mankowski Walter C.,Liu Michael,Ha Richard,Pellicer-Valero Oscar J.,Maier-Hein Klaus,Rabinovici-Cohen Simona,Tlusty Tal,Ozery-Flato Michal^ORCID,Parekh Vishwa S.^ORCID,Jacobs Michael A.,Yan Ran,Sung Kyunghyun^ORCID,Kazerouni Anum S.^ORCID,DiCarlo Julie C.,Yankeelov Thomas E.^ORCID,Chenevert Thomas L.^ORCID,Hylton Nola M.^ORCID

Funder

National Institutes of Health

Defense Advanced Research Projects Agency

Cancer Prevention and Research Institute of Texas

Publisher

Radiological Society of North America (RSNA)

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/rycan.230033

Reference18 articles.

1. Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial

2. Repeatability and Reproducibility of ADC Histogram Metrics from the ACRIN 6698 Breast Cancer Therapy Response Trial

3. Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial

4. Challenges Related to Artificial Intelligence Research in Medical Imaging and the Importance of Image Analysis Competitions

5. Test–retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial